September 5, 2025 - 02:24

The Woolies CEO has openly acknowledged that the latest round of collectables did not resonate well with customers, marking a significant misstep for the retail giant. This admission comes as part of a broader reflection on the company's strategy to engage consumers through collectible items, which traditionally have been a popular draw.
The CEO revealed that the recent collectables were perceived as "expensive" and did not meet the expectations of shoppers. This feedback highlights the importance of understanding consumer preferences and pricing strategies in a competitive market.
In response to the backlash, Woolworths is committed to reevaluating its approach to future collectable campaigns. The company aims to ensure that upcoming offerings align more closely with customer desires and budget considerations. As the retail landscape continues to evolve, Woolworths is taking proactive steps to learn from this experience and avoid similar pitfalls in the future, reaffirming its dedication to customer satisfaction.
June 3, 2026 - 07:37
Japan finance minister says ready to respond appropriately on forexTOKYO, June 3 - Japanese Finance Minister Satsuki Katayama stated on Wednesday that the government is prepared to take appropriate measures in the foreign exchange market, issuing a fresh warning...
June 2, 2026 - 17:28
Thrifts & Mortgage Finance Stocks Q1 Results: Benchmarking Franklin BSP Realty Trust (NYSE:FBRT)The close of earnings season offers a useful moment to check in on how different sectors are navigating the current economic climate. For investors keeping an eye on thrifts and mortgage finance...
June 2, 2026 - 05:00
HPE expects to achieve 2028 financial targets this year after record quarter on AI boomHewlett Packard Enterprise reported record revenue for its second fiscal quarter on Monday, driven by surging demand for AI data center infrastructure. The strong performance has led the company to...
June 1, 2026 - 02:50
This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First QuarterA recent $5.5 million executive departure at Wave Life Sciences has drawn scrutiny following the company`s disappointing first-quarter performance. The clinical-stage biotech, which develops...